| NCT Number | NCT06517940 |
| Lead Sponsor | Sumitomo Pharma America, Inc. |
| Conditions | Retinitis Pigmentosa |
| Enrollment | 12 participants |
| Start Date | 2024-10-03 |
| Primary Completion | 2026-04-24 (estimated) |
| Study Completion | 2026-04-24 (estimated) |
| Updated on ClinicalTrials.gov | 2026-02-27 |